Bénédicte Caron

Apr 24, 2023 | mdpi.com | Ferdinando D’Amico |Sophie Vieujean |Bénédicte Caron |Laurent Peyrin-Biroulet

Abstract:Background: Treatment choices for patients with inflammatory bowel disease (IBD) are based on the balance between risks and benefits. Our AI was to compare the perspectives of patients and physicians in evaluating the risks and benefits before initiating therapy for IBD. Methods: An anonymous survey was conducted between March and August 2022. All patients with confirmed IBD and all physicians who attended an IBDscope webinar were invited to participate.